Agilon Health (AGL) Competitors

Agilon Health logo
$114.75 -2.00 (-1.71%)
As of 03:11 PM Eastern
This is a fair market value price provided by Massive. Learn more.

AGL vs. RDNT, HIMS, LFST, BLLN, and OPCH

Should you buy Agilon Health stock or one of its competitors? Agilon Health's main competitors and comparable companies include RadNet (RDNT), Hims & Hers Health (HIMS), LifeStance Health Group (LFST), Billiontoone (BLLN), and Option Care Health (OPCH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Agilon Health compare to RadNet?

RadNet (NASDAQ:RDNT) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

RadNet has a net margin of -0.94% compared to Agilon Health's net margin of -1.45%. RadNet's return on equity of 3.14% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.94% 3.14% 1.08%
Agilon Health -1.45%-51.97%-7.15%

RadNet has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market. Comparatively, Agilon Health has a beta of 3.1, indicating that its share price is 210% more volatile than the broader market.

77.9% of RadNet shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Comparatively, 2.5% of Agilon Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

RadNet has higher earnings, but lower revenue than Agilon Health. RadNet is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$2.04B2.97-$18.65M-$0.29N/A
Agilon Health$5.93B0.33-$391.35M-$5.55N/A

In the previous week, RadNet had 13 more articles in the media than Agilon Health. MarketBeat recorded 18 mentions for RadNet and 5 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.93 beat RadNet's score of 0.73 indicating that Agilon Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
6 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Agilon Health
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

RadNet presently has a consensus price target of $89.67, indicating a potential upside of 16.62%. Agilon Health has a consensus price target of $107.38, indicating a potential downside of 8.45%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts clearly believe RadNet is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.78
Agilon Health
2 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

RadNet beats Agilon Health on 13 of the 17 factors compared between the two stocks.

How does Agilon Health compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Hims & Hers Health currently has a consensus price target of $31.53, suggesting a potential upside of 70.11%. Agilon Health has a consensus price target of $107.38, suggesting a potential downside of 8.45%. Given Hims & Hers Health's higher probable upside, research analysts plainly believe Hims & Hers Health is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.13
Agilon Health
2 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.33

Hims & Hers Health has higher earnings, but lower revenue than Agilon Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B1.84$128.37M-$0.83N/A
Agilon Health$5.93B0.33-$391.35M-$5.55N/A

Agilon Health has a net margin of -1.45% compared to Hims & Hers Health's net margin of -6.65%. Hims & Hers Health's return on equity of -9.62% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-6.65% -9.62% -1.38%
Agilon Health -1.45%-51.97%-7.15%

63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 2.5% of Agilon Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Hims & Hers Health had 45 more articles in the media than Agilon Health. MarketBeat recorded 50 mentions for Hims & Hers Health and 5 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.93 beat Hims & Hers Health's score of -0.29 indicating that Agilon Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
1 Very Positive mention(s)
5 Positive mention(s)
17 Neutral mention(s)
20 Negative mention(s)
2 Very Negative mention(s)
Neutral
Agilon Health
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health has a beta of 2.53, suggesting that its share price is 153% more volatile than the broader market. Comparatively, Agilon Health has a beta of 3.1, suggesting that its share price is 210% more volatile than the broader market.

Summary

Hims & Hers Health beats Agilon Health on 9 of the 16 factors compared between the two stocks.

How does Agilon Health compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

In the previous week, LifeStance Health Group had 8 more articles in the media than Agilon Health. MarketBeat recorded 13 mentions for LifeStance Health Group and 5 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.93 beat LifeStance Health Group's score of 0.38 indicating that Agilon Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
5 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Agilon Health
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LifeStance Health Group has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market. Comparatively, Agilon Health has a beta of 3.1, meaning that its share price is 210% more volatile than the broader market.

LifeStance Health Group currently has a consensus price target of $14.86, indicating a potential upside of 2.60%. Agilon Health has a consensus price target of $107.38, indicating a potential downside of 8.45%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, research analysts plainly believe LifeStance Health Group is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70
Agilon Health
2 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.33

LifeStance Health Group has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B3.87$9.66M$0.1976.21
Agilon Health$5.93B0.33-$391.35M-$5.55N/A

LifeStance Health Group has a net margin of 4.29% compared to Agilon Health's net margin of -1.45%. LifeStance Health Group's return on equity of 4.82% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group4.29% 4.82% 3.30%
Agilon Health -1.45%-51.97%-7.15%

85.5% of LifeStance Health Group shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Comparatively, 2.5% of Agilon Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

LifeStance Health Group beats Agilon Health on 13 of the 17 factors compared between the two stocks.

How does Agilon Health compare to Billiontoone?

Agilon Health (NYSE:AGL) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

Billiontoone has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.33-$391.35M-$5.55N/A
Billiontoone$305.11M15.08$7.45M$0.92104.68

Billiontoone has a net margin of 10.95% compared to Agilon Health's net margin of -1.45%. Billiontoone's return on equity of 9.16% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-1.45% -51.97% -7.15%
Billiontoone 10.95%9.16%6.78%

Agilon Health presently has a consensus price target of $107.38, suggesting a potential downside of 8.45%. Billiontoone has a consensus price target of $124.38, suggesting a potential upside of 29.14%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts plainly believe Billiontoone is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
2 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.33
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

In the previous week, Billiontoone had 3 more articles in the media than Agilon Health. MarketBeat recorded 8 mentions for Billiontoone and 5 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.93 beat Billiontoone's score of 0.33 indicating that Agilon Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilon Health
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Billiontoone beats Agilon Health on 10 of the 12 factors compared between the two stocks.

How does Agilon Health compare to Option Care Health?

Option Care Health (NASDAQ:OPCH) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk and media sentiment.

Option Care Health has a beta of 0.47, indicating that its share price is 53% less volatile than the broader market. Comparatively, Agilon Health has a beta of 3.1, indicating that its share price is 210% more volatile than the broader market.

98.1% of Option Care Health shares are held by institutional investors. 1.7% of Option Care Health shares are held by company insiders. Comparatively, 2.5% of Agilon Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Option Care Health has a net margin of 3.74% compared to Agilon Health's net margin of -1.45%. Option Care Health's return on equity of 19.06% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Option Care Health3.74% 19.06% 7.32%
Agilon Health -1.45%-51.97%-7.15%

Option Care Health has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Option Care Health$5.65B0.84$207.59M$1.3922.81
Agilon Health$5.93B0.33-$391.35M-$5.55N/A

In the previous week, Agilon Health had 1 more articles in the media than Option Care Health. MarketBeat recorded 5 mentions for Agilon Health and 4 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.65 beat Agilon Health's score of 0.93 indicating that Option Care Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Option Care Health
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Agilon Health
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Option Care Health presently has a consensus target price of $29.48, indicating a potential downside of 7.04%. Agilon Health has a consensus target price of $107.38, indicating a potential downside of 8.45%. Given Option Care Health's higher possible upside, analysts clearly believe Option Care Health is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Option Care Health
0 Sell rating(s)
14 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.13
Agilon Health
2 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Option Care Health beats Agilon Health on 10 of the 16 factors compared between the two stocks.

Get Agilon Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGL vs. The Competition

MetricAgilon HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$1.93B$10.57B$7.73B$22.87B
Dividend YieldN/A2.54%2.46%3.79%
P/E Ratio-20.6935.8034.1629.08
Price / Sales0.322.088.473.28
Price / CashN/A23.3421.9315.51
Price / Book6.863.594.373.61
Net Income-$391.35M$332.46M$3.52B$1.08B
7 Day Performance1.07%-4.09%-5.48%-3.72%
1 Month Performance34.91%-1.81%-4.62%-2.47%
1 Year Performance754.78%18.67%-1.57%6.17%

Agilon Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGL
Agilon Health
1.5447 of 5 stars
$114.75
-1.7%
$107.38
-6.4%
+715.9%$1.93B$5.93BN/A856
RDNT
RadNet
3.542 of 5 stars
$78.38
+3.1%
$90.00
+14.8%
+2.3%$6.32B$2.04B182.4111,264
HIMS
Hims & Hers Health
2.8033 of 5 stars
$22.90
-11.9%
$32.43
+41.6%
-50.0%$6.22B$2.35BN/A2,442
LFST
LifeStance Health Group
3.015 of 5 stars
$14.60
+6.0%
$13.75
-5.8%
+126.3%$5.43B$1.42B76.8510,961
BLLN
Billiontoone
3.4668 of 5 stars
$114.95
+0.9%
$126.88
+10.4%
+7.0%$5.37B$305.11M123.79713

Related Companies and Tools


This page (NYSE:AGL) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners